Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axogen Inc (AXGN) vs Williams-Sonoma, Inc. (WSM) Price & Performance

Axogen IncTrade
Williams-Sonoma, Inc.Trade

Price performance (Past 24H)

Key statistics

Axogen Inc vs Williams-Sonoma, Inc. — how do they compare? Axogen Inc trades at $49.24 (market cap $2.61B), while Williams-Sonoma, Inc. trades at $246.05 (market cap $29.51B). The key difference: Williams-Sonoma, Inc. is far larger — about 11.3× Axogen Inc's market cap, and Williams-Sonoma, Inc. pays a 1.21% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.

AXGNWSM
Market Cap
$2.61B$29.51B
Sector
TechnologyConsumer Cyclical
52-Week High
$48.48$251.81
52-Week Low
$14.16$168.64
Enterprise Value
$2.52B$30.35B
Dividend Yield
1.21%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axogen Inc

AXGN trades at $49.10, up 1.82% with strong technical momentum and bullish analyst sentiment. The stock shows robust revenue growth (23.1% in Q2 2026) and raised full-year guidance to $279 million, though profitability remains negative with a -13.36% net margin. Technical indicators show overbought RSI levels but strong moving average support, while institutional ownership and analyst consensus (84% buy ratings) signal confidence in the company's nerve care platform expansion.

The outlook remains positive given strong revenue momentum and regulatory advantages, but investors face execution risks from persistent losses and high valuation multiples. Upside potential exists toward the $54.33 consensus target if margin improvements materialize, though volatility may persist near current resistance levels.

Williams-Sonoma, Inc.

Williams-Sonoma (WSM) trades at $246.14, down 1.87% on the day, amid a generally bullish technical outlook. The stock shows strong profitability with a net income margin of 13.81% and has beaten earnings estimates for three consecutive quarters. Recent news highlights its digital-first transformation and competitive strength in home furnishings.

The outlook is supported by solid fundamentals and positive earnings momentum, but high valuation ratios and overbought RSI levels pose near-term risks. Analyst consensus is mixed, with a moderate buy rating but a price target below the current price, suggesting cautious optimism amid execution and consumer spending concerns.

Returns comparison

Trailing returns across standard periods

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN

About Williams-Sonoma, Inc.

With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.

Read more on WSM